바이오 분석 검사 서비스 시장 보고서 : 분자 유형, 검사 유형, 워크플로우, 지역별(2024-2032년)

The global bioanalytical testing services market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032.

Bioanalytical testing services are used for the quantitative determination of drugs concentration and their metabolites and pharmacodynamic biomarkers in biological fluids. These services include method validation for ensuring results that demonstrate accuracy, precision, selectivity, and stability and assure the accuracy of sample analysis results. Nowadays, they rely on developed and validated methods for detecting analytes and metabolites in a diversity of complex biological matrices. Some of these matrices are urine, serum, blood, saliva, plasma, breast milk, cell lysates, cell culture media, tissue homogenates, cerebrospinal fluid (CSF), and wastewater from pharmaceutical production.

Bioanalytical Testing Services Market Trends:

The increasing occurrence of chronic health conditions worldwide on account of sedentary lifestyles and increasing consumption of fast food, along with the rising preferences for personalized medical treatments, represents one of the key factors influencing the market positively. Additionally, biopharmaceutical companies are using bioanalytical testing services for validation of assays and drug development at both preclinical and clinical stages. Moreover, the global transmission of the coronavirus disease (COVID-19) and the lack of effective vaccines and treatments are driving the need for widespread screening and early detection. This has increased the usage of bioanalytical testing services for point-of-care (POC) diagnostic and controlling the spread and minimizing the resultant health and societal impact of the infection. Apart from this, several companies are incorporating a wide range of innovative techniques to offer rapid high-volume analyses. These techniques generally include mass spectrometry, immunochemistry, Ultra-Performance Liquid Chromatography (UPLC), automated sample preparation using robotics or turbulent flow, and large sample storage combined with bar code systems. This, in confluence with the improving healthcare infrastructure, is strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioanalytical testing services market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on molecule type, test type and workflow.

Breakup by Molecule Type:

Small Molecule

Large Molecule

LC-MS Studies

Immunoassays

Others

Breakup by Test Type:

ADME

In-Vivo

In-Vitro

PK

PD

Bioavailability

Bioequivalence

Others

Breakup by Workflow:

Sample Preparation

Protein Precipitation

Liquid-Liquid Extraction

Solid Phase Extraction

Sample Analysis

Hyphenated Technique

Chromatographic Technique

Electrophoresis

Ligand Binding Assay

Mass Spectrometry

Nuclear Magnetic Resonance

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Almac Group, Charles River Laboratories International Inc., Frontage Laboratories Inc., ICON plc, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, PPD Inc., PRA Health Sciences, SGS SA, Syneos Health and Toxikon Corporation.

Key Questions Answered in This Report

• 1. What was the size of the global bioanalytical testing services market in 2023?
• 2. What is the expected growth rate of the global bioanalytical testing services market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global bioanalytical testing services market?
• 4. What are the key factors driving the global bioanalytical testing services market?
• 5. What is the breakup of the global bioanalytical testing services market based on the molecule type?
• 6. What is the breakup of the global bioanalytical testing services market based on the test type?
• 7. What is the breakup of the global bioanalytical testing services market based on the workflow?
• 8. What are the key regions in the global bioanalytical testing services market?
• 9. Who are the key players/companies in the global bioanalytical testing services market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bioanalytical Testing Services Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Molecule Type

• 6.1 Small Molecule
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Large Molecule
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 LC-MS Studies
    • 6.2.2.2 Immunoassays
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast

7 Market Breakup by Test Type

• 7.1 ADME
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 In-Vivo
    • 7.1.2.2 In-Vitro
  • 7.1.3 Market Forecast
• 7.2 PK
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 PD
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Bioavailability
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Bioequivalence
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Workflow

• 8.1 Sample Preparation
  • 8.1.1 Market Trends
  • 8.1.2 Key Segments
    • 8.1.2.1 Protein Precipitation
    • 8.1.2.2 Liquid-Liquid Extraction
    • 8.1.2.3 Solid Phase Extraction
  • 8.1.3 Market Forecast
• 8.2 Sample Analysis
  • 8.2.1 Market Trends
  • 8.2.2 Key Segments
    • 8.2.2.1 Hyphenated Technique
    • 8.2.2.2 Chromatographic Technique
    • 8.2.2.3 Electrophoresis
    • 8.2.2.4 Ligand Binding Assay
    • 8.2.2.5 Mass Spectrometry
    • 8.2.2.6 Nuclear Magnetic Resonance
  • 8.2.3 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Almac Group
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Charles River Laboratories International Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Frontage Laboratories Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 ICON plc
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Intertek Group plc
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Laboratory Corporation of America Holdings
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Pace Analytical Services LLC
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 PPD Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 PRA Health Sciences
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 SWOT Analysis
  • 14.3.10 SGS SA
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Syneos Health
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Toxikon Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio